America, America. Can’t say we don’t know how to make money. Especially off of dying people.
I mean, you know, suck it up. You’ve got kidney disease, and you’re going to die… So you’re going to shell out the $23,000 for that little vial. Aren’t you?
Which is going to make one particular university professor very happy. Columbia University’s Andrew Bomback, in what sounds like the same form of business relationship Chip Skowron cultivated, has been talking to rich hedgies about his medical research… and it all has that je ne sais quoi, insidery tradery, feel to it, according to the state of Massachusetts.
Mr. Silverman [the hedgie], after talking with Dr. Bomback on June 14, 2010, invested $846,889 in Questcor [the company with the little vials] between July 6 and Sept. 9, the Massachusetts filing showed. He paid an average of $9.80 a share. The stock closed Friday at $27.27 a share, giving him a paper gain of $1.5 million.
September 18th, 2011 at 1:57AM
Gaming the system – that’s the new entitlement of academic entrepreneurs.